November 3, 2025 SARC044 Completes Enrollment SARC is pleased to announce the successful completion of patient enrollment for SARC044. Read more
October 30, 2025 SARC045 Opens to Enrollment SARC is excited to announce that SARC045 is now open and actively recruiting patients. Read more
March 27, 2025 SARC Seeks Medical Monitor to Support Sarcoma Clinical Trials Position is ideal for physicians with experience in oncology clinical trials who are dedicated to advancing sarcoma research. Read more
August 20, 2024 SARC 044 Open for Enrollment SARC’s newest clinical trial, SARC044, is now open for enrollment! This trial aims to enroll patients with GIST who have previously progressed on sunitinib. Read more
June 13, 2024 SARC037 Progress Announced at ASCO 2024 Dr. Patrick Grohar presented the SARC037 findings at ASCO 2024. The results suggest that EWS::FLI1 is a target for Ewing sarcoma and the combination of trabectedin/irinotecan is active in treatment-refractory Ewing sarcoma patients. Read more
June 10, 2024 Sarcoma Centers Spotlight In this SARC Sarcoma Centers Spotlight we feature Jessica Lowenstein, M.S., DABR, a medical physicist, and Hannah Nguyen, M.S. (RS), CMD, a medical dosimetrist, both of whom work at RQA Lab and IROC Houston located at MD Anderson Cancer Center. Read more
June 7, 2024 SU2C-SARC032 Positive Results Revealed at ASCO Dr. David Kirsch unveiled the SU2C-SARC032 findings at ASCO 2024. The results indicate that adding pembro decreases the risk of cancer recurrence by 43% two years after treatment. Read more
May 24, 2024 Advancements in GIST Research to be Announced at ASCO SARC, alongside sarcoma research leaders like Cogent Biosciences, Dana Farber Cancer Institute and The Life Raft Group, is committed to collaborating to advance treatment options for GIST patients. Read more
April 23, 2024 SARC-Sponsored Studies Selected for Oral Presentations at ASCO SARC032 and SARC037 to be presented at ASCO 2024. Read more
July 14, 2023 SARC037 is Open and Accruing In a rare disease as Ewing sarcoma, we recognize we need to work together to complete important studies like this. Read more